Los Angeles, CA -- (SBWIRE) -- 05/07/2019 -- Cetirizine Hydrochloride (trade names Zirtec, Zyrtec, Reactine) is a second-generation antihistamine used in the treatment of hay fever, allergies, angioedema, and urticaria.[1] It is a major metabolite of hydroxyzine, and a racemic selective H1 receptor antagonist.
The global average price of Cetirizine Hydrochloride is in the decreasing trend, from 52.7 USD/K Units in 2012 to 47.7 USD/K Units in 2017. With the situation of global economy and increasing generic medicine, prices will be in decreasing trend in the following five years.
The classification of Cetirizine Hydrochloride includes tablet, capsule and solution, and tablet type of Cetirizine Hydrochloride is the largest segment in the market, its proportion in 2016 is about 45%. Cetirizine Hydrochloride is widely consumed in hospitals, clinics and drug store. The most large application proportion of Cetirizine Hydrochloride is drug store.
Get PDF template of this report: https://www.qyresearch.com/sample-form/form/1089043/global-cetirizine-hydrochloride-market
Europe is the largest supplier of Cetirizine Hydrochloride, with a production market share over 50% in 2016. USA is the second largest supplier of Cetirizine Hydrochloride products, enjoying production market share nearly 28% in 2016.
The global Cetirizine Hydrochloride market was 1100 million US$ in 2018 and is expected to 1410 million US$ by the end of 2025, growing at a CAGR of 3.2% between 2019 and 2025.
This report studies the Cetirizine Hydrochloride market size (value and volume) by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Cetirizine Hydrochloride in these regions, from 2014 to 2025, covering
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia and Turkey etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil etc.)
Middle East and Africa (Egypt and GCC Countries)
The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in this market include
UCB Pharma
Pfizer
J & J
Mylan
Teva
HUAPONT Pharm
Hunan Jiudian Pharm
Sun Pharma
Lunan Pharma
Jubilant Life Sciences
Amneal
HAILISHENG
By the product type, the market is primarily split into
Tablet
Capsule
Solution
By the end users/application, this report covers the following segments
Hospital
Clinic
Drug Store
We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
Rest of Middle East & Africa
The study objectives of this report are:
To study and analyze the global Cetirizine Hydrochloride market size (value & volume) by company, key regions/countries, products and application, history data from 2014 to 2018, and forecast to 2025.
To understand the structure of Cetirizine Hydrochloride market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Cetirizine Hydrochloride manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Cetirizine Hydrochloride with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Cetirizine Hydrochloride submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Get Full Report Now at USD 3,550 @ https://www.qyresearch.com/settlement/pre/15d521a62201a91b3d2437db3f790569,0,1,Global%20Cetirizine%20Hydrochloride%20Market%20Report,%20History%20and%20Forecast%202014-2025,%20Breakdown%20Data%20by%20Manufacturers,%20Key%20Regions,%20Types%20and%20Application
About QYResearch
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from the huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in the consulting industry.